Chief Scientific Officer
Yvonne McGrath has 14 years of biotech and pharma industry experience. Before joining Complix as CSO in May 2014, she was Head of Development at Immunocore, and before that Head of Preclinical Development and CMC. In these positions, she successfully developed and executed the late preclinical and early clinical strategy for a novel platform technology and led manufacturing and CMC strategy for a new biological entity targeting cancer. Yvonne´s previous experience includes being a Project Manager at the UK subsidiary of the German biotech company MediGene AG, and Senior Scientist at BioVex (now part of Amgen). At BioVex, she was involved in developing a viral delivery mechanism for the immunotherapeutic treatment of melanoma. Yvonne holds a PhD from the University of Wales, College of Medicine.